University of the Incarnate Word Feik School of Pharmacy
Pharmacotherapy Residency
Cardiology Rotation
Preceptor:
Preceptor:
Position:
Office Phone:
Cell Phone:
Email Address:
Site:
Bethany A. Kalich, PharmD, BCPS
Assistant Professor, University of the Incarnate Word Feik School of Pharmacy
(210) 883-1177
(210) 844-4330
kalich@uiwtx.edu
Cardiology Acute Care Unit and Intensive Care Unit, University Hospital
General Description:
This cardiology rotation is an elective rotation for UIW pharmacotherapy residents. The 4-week rotation involves the
design of evidence-based patient-specific regimens and the evaluation of outcomes for patients on the cardiology service at
University Health System.
The purpose of this rotation is expose the resident to a variety of cardiovascular disease states which will facilitate learning
how to optimize patient care through application of primary literature and evidence-based guideline recommendations.
The key to success is a solid understanding of cardiovascular physiology/pathophysiology, dedication of time to literature
evaluation and a desire to develop reliable and accountable working relationships with the cardiology patients and team
members. The cardiology team is composed of an attending, cardiology fellow, two to three internal medicine residents,
two to three interns from family medicine, internal medicine, radiology or emergency medicine, and medical students.
Disease States:
The resident will be expected to gain knowledge of the pathophysiology and pharmacotherapeutic management of patients
with various cardiovascular illnesses, and associated internal medicine and critical care related illnesses, through topic
discussion and the direct patient care learning experience. Topics to be addressed will include (but are not limited
1.
2.
3.
4.
5.
6.
7.
8.
Cardiovascular: dyslipidemia, dysrhythmias, heart failure, hypertension, ischemic heart disease, pericarditis,
valvular disorders, venous thromboembolism
Endocrine: diabetes mellitus, thyroid disorders
Hematologic: anemia, clotting factor disorders, venous thromboembolism
Infectious Diseases: community acquired pneumonia, gastrointestinal infections, infectious endocarditis,
nosocomial pneumonia, urinary tract infections
Neurological: acute pain, chronic pain
Psychiatric: drug/alcohol overdose/withdrawal
Renal: acute kidney injury, chronic kidney disease, dialysis (managing associated complications and drug dosing)
Respiratory: COPD, pulmonary hypertension
1
Goals and Objectives to be Taught and Formally Evaluated:
Goal
Objective
Activity
Patient Care: PGY1 Competency Area R1 and PGY2 Competency Area R2 and R3
GOAL R1.1
In collaboration with the
health care team, provide safe
and effective patient care to a
diverse range of
patients…following a
consistent patient care
process.
Objective R1.1.1: (Applying) Interact
effectively with health care teams to
manage patients’ medication therapy.
• Participate in patient rounds as scheduled
Objective R1.1.5: (Creating) Design or
redesign safe and effective patientcentered therapeutic regimens and
monitoring plans (care plans).
• Use evidence-based consensus guidelines
Objective R1.1.6: (Applying) Ensure
implementation of therapeutic regimens
and monitoring plans (care plans) by
taking appropriate follow-up actions.
• Construct a medication monitoring plan for
and communicate information with healthcare team and inpatient pharmacy.
• Communicate recommendations for
therapeutic regimens and monitoring plans
to team members during daily rounds and
as required.
to specify and design therapeutic goals for
each patient.
• Collect, interpret, and evaluate results of
monitoring parameters, including labs,
drug levels, clinical response, etc.
• Redesign monitoring plan as necessary.
• Recognize factors that may influence
therapeutic goals such as cultural, ethical,
mental, financial, and age-related barriers.
each patient followed by the service based
on individual patient data, including age,
race, gender, organ function, and disease
state.
• Devise specific monitoring plans for
patients receiving agents that require
therapeutic drug monitoring.
• Follow up daily after rounds to ensure that
recommendations for medication regimens
and monitoring are implemented.
• Contact prescriber directly when required
and enter orders in patient’s chart as a
verbal or telephone order if needed.
Advancing Practice and Improving Patient Care: PGY1 Competency Area R2 and PGY2 Competency
Area R3
Goal R2.1
Objective 2.1.4: (Applying) Participate in
Demonstrate ability to manage medication event reporting and
formulary and medication-use monitoring.
processes, as applicable to the
organization.
• Effectively uses currently available
technology and automation that supports
a safe medication-use process.
• Appropriately and accurately determines,
investigates, reports, tracks and trends
adverse drug events, medication errors
and efficacy concerns using accepted
institutional resources and programs
2
Teaching, Education, Dissemination of Knowledge: PGY1 and PGY2 Competency Area R4 and PGY1
Competency E6
GOAL R4.1
Objective R4.1.1: (Applying) Design
Provide effective medication
effective educational activities.
and practice-related education
to patients, caregivers, health
care professionals, students,
and the public.
• Accurately defines learning needs (e.g.,
•
•
•
•
Objective R4.1.2: (Applying) Use
effective presentation and teaching skills
to deliver education.
level, such as healthcare professional vs
patient, and their learning gaps) of
audience (individuals or groups).
Defines educational objectives that are
specific, measurable, at a relevant learning
level (e.g., applying, creating, evaluating),
and that address the audiences’ defined
learning needs.
Plans use of teaching strategies that match
learner needs, including active learning
(e.g., patient cases, polling).
Selects content that is relevant, thorough,
evidence-based (using primary literature
where appropriate), and timely, and
reflects best practices.
Includes accurate citations and relevant
references, and adheres to applicable
copyright laws.
• Demonstrates rapport with learners.
• Captures and maintains learner/audience
interest throughout the presentation.
• Implements planned teaching strategies
•
•
•
•
•
•
effectively.
Effectively facilitates audience
participation, active learning, and
engagement in various settings (e.g., small
or large group, distance learning).
Presents at appropriate rate and volume
and without distracting speaker habits
(e.g., excessive “ah’s” and “um’s”).
Body language, movement, and
expressions enhance presentations.
Summarizes important points at
appropriate times throughout
presentations.
Transitions smoothly between concepts.
Effectively uses audio-visuals and
handouts to support learning activities.
Schedule and Preceptor Interaction:
5:00 to 7:15 AM
7:15 to 8:00 AM
8:00 to 12:00 PM
After 12:00 PM
Work up patients
Discuss patients with preceptor
Multidisciplinary rounds with cardiology team
Follow-up on patient issues from rounds
Topic discussions and student or resident case presentations
3
Communication:
•
•
•
Daily scheduled meeting times: Residents to prioritize questions and problems to discuss during scheduled
meeting times as listed above.
E-mail: Residents are expected to read e-mails daily at a minimum for ongoing communication. This is appropriate
for routine, non-urgent questions and problems.
Cell phone: Residents can text for non-urgent questions and problems. All urgent/emergency situations
pertaining to patient care should be communicated via phone call.
Expected Progression of Resident Responsibility:
Day 1
Preceptor to review learning activities and experiences with resident.
Week 1
Resident to work up approximately one-half of the team’s patients and present to preceptor daily.
Preceptor to attend and participate in team rounds with resident, modeling pharmacist’s role on
health care team.
Week 2
Resident to work up all of the team’s patients and discuss problems with preceptor daily. Preceptor to
attend team rounds with resident, coaching resident to take on more responsibilities as the pharmacist
on the team.
Week 3
Resident will continue to be responsible for all of the team's patients, continuing to discuss identified
problems with preceptor daily. The preceptor will attend team rounds two to three days this week
facilitating the transition to the resident as the pharmacist on the team.
Week 4
Resident will continue to be responsible for all of the team's patients, continuing to discuss identified
problems with preceptor daily. The preceptor will no longer attend team rounds, but will continue to
facilitate the resident as the pharmacist on the team.
Evaluation:
Completion of this rotation will be determined by the resident’s ability to meet the goals and objectives of this rotation as
established by the residency director. The resident and preceptor will independently complete the assigned evaluation and
save as a draft. The resident and preceptor will then compare and discuss the evaluations. This discussion will provide
feedback both on performance of the activities and the accuracy of the resident’s self-assessment skills.
Summative Evaluation: This evaluation summarizes the resident’s performance throughout the learning experience.
Specific comments and examples should be included to provide the resident with information they can use to improve their
performance in subsequent learning experiences.
Preceptor and Learning Experience Evaluation: The resident will complete this prior to the last day of the learning
experience.
A final copy of all evaluations should be placed in the resident’s portfolio.
4